CellSource Co., Ltd.
TSE:4880.T
608 (JPY) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,355.063 | 4,510.544 | 4,273.829 | 2,922.232 | 1,855.475 | 1,611.587 | 1,212.73 | 519.062 |
| Cost of Revenue
| 1,937.651 | 1,326 | 1,209.528 | 848.207 | 596.519 | 457.989 | 336.803 | 219.136 |
| Gross Profit
| 2,417.412 | 3,184.544 | 3,064.301 | 2,074.025 | 1,258.956 | 1,153.598 | 875.927 | 299.926 |
| Gross Profit Ratio
| 0.555 | 0.706 | 0.717 | 0.71 | 0.679 | 0.716 | 0.722 | 0.578 |
| Reseach & Development Expenses
| 71.009 | 72.453 | 87.562 | 71.161 | 10.817 | 7.999 | 6.88 | 4.089 |
| General & Administrative Expenses
| 290.75 | 302.43 | 324.047 | 204.85 | 169.857 | 145.468 | 247.157 | 77.627 |
| Selling & Marketing Expenses
| 105.063 | 103.893 | 101.434 | 93.878 | 122.883 | 199.658 | 183.127 | 23.189 |
| SG&A
| 395.813 | 406.323 | 425.481 | 298.728 | 292.74 | 345.126 | 430.284 | 100.816 |
| Other Expenses
| 1,821.432 | 1,484.721 | 980.2 | 711.69 | 539.844 | 473.525 | 143.667 | 0.002 |
| Operating Expenses
| 2,288.254 | 1,963.497 | 1,493.243 | 1,081.579 | 843.401 | 826.65 | 580.831 | 140.764 |
| Operating Income
| 129.158 | 1,221.499 | 1,571.052 | 992.441 | 415.551 | 326.944 | 295.092 | 159.156 |
| Operating Income Ratio
| 0.03 | 0.271 | 0.368 | 0.34 | 0.224 | 0.203 | 0.243 | 0.307 |
| Total Other Income Expenses Net
| 165.783 | 18.183 | 12.587 | 13.926 | -2.744 | -23.598 | -0.543 | -0.16 |
| Income Before Tax
| 294.941 | 1,239.682 | 1,583.639 | 1,006.367 | 412.807 | 303.346 | 294.549 | 158.84 |
| Income Before Tax Ratio
| 0.068 | 0.275 | 0.371 | 0.344 | 0.222 | 0.188 | 0.243 | 0.306 |
| Income Tax Expense
| 57 | 316.54 | 565.796 | 354.971 | 138.725 | 103.74 | 101.149 | 47.439 |
| Net Income
| 237.94 | 923.142 | 1,017.842 | 651.396 | 274.082 | 199.606 | 193.4 | 111.4 |
| Net Income Ratio
| 0.055 | 0.205 | 0.238 | 0.223 | 0.148 | 0.124 | 0.159 | 0.215 |
| EPS
| 12.01 | 48.88 | 54.54 | 35.17 | 15.19 | 11.55 | 14.92 | 6.45 |
| EPS Diluted
| 11.96 | 47.93 | 52.98 | 33.91 | 14.33 | 11.55 | 14.92 | 6.45 |
| EBITDA
| 449.53 | 1,306.44 | 1,644.798 | 1,061.566 | 476.457 | 365.444 | 309.643 | 169.928 |
| EBITDA Ratio
| 0.103 | 0.29 | 0.385 | 0.363 | 0.257 | 0.227 | 0.255 | 0.327 |